ABPI Eschews Trial Data
UK Turns to Real-World Data To Bolster Drug Reimbursement
By Nuala Moran
Wednesday, October 12, 2011
LONDON The UK biopharmaceutical industry is preparing a new defense against the incursions that health technology assessments (HTA) are making on its ability to get reimbursement for some drugs and the full price for others, turning to real-world data to demonstrate the value of its products. (BioWorld International)
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.